Department News

The fund will support research and PhD students within the Department of Pharmacological Sciences at Stony Brook.

The family of Arthur Grollman, MD, has established an endowed pharmacology fund at Stony Brook University to honor the late Distinguished Professor. In addition, the Arthur P. Grollman Seminar Room was named for him in the Basic Science Tower within the Department of Pharmacological Sciences.

18th Annual Molecular & Cellular Pharmacology Graduate Student Symposium.

Click here to view Symposium flyer.

This award was developed by faculty for faculty, and only those who have demonstrated a record of sustained, superior service to a wide range of diverse constituents receive this distinction.  Dr. Colognato's contributions to the profession, the campus, SUNY, and the broader community are reflected in her selection for this honor.  Receiving this nomination underscores the respect and esteem of Dr. Colognato's colleagues, students, and campus leadership for her professional accomplishments.

This award was developed by faculty for faculty, and only those who have demonstrated a record of sustained scholarship in the sciences, humanities, and professional studies, or consistent creative productivity in the fine and performing arts receive this distinction.  Dr. Takemaru's contributions to developing new knowledge, enhancing the University's vibrancy, and fostering the intellectual and cultural growth of its students are reflected in his selection for this honor.  Receiving this nomination underscores the respect and esteem of Dr.

Dr. Arthur P. Grollman, Distinguished Professor of Pharmacological Sciences, Evelyn G. Glick Professor of Experimental Medicine, and Director of the Zickler Laboratory of Chemical Biology at Stony Brook University School of Medicine—In 1974, Arthur P. Grollman was appointed Chairman (founding) of the Department of Pharmacological Sciences. Under his leadership, Pharmacological Sciences consistently ranked among the top Departments of Pharmacology in the United States.

• Read more about 2023 OVPR Seed Grant Program Winners - Congratulations to Holly Colognato and Ken-Ichi Takemaru

In 1982, researchers discovered the first family of cancer-causing genes, which included the Kirsten rat sarcoma virus (KRAS), a gene that provides instructions for making a protein called K-Ras that relays signals from outside the cell to the cell’s nucleus. The KRAS gene is estimated to be a factor in up to 30 percent of all human cancers, including lung, pancreatic and colorectal cancer. At the time, the protein was deemed “undruggable.”

The Institute of Chemical Biology & Drug Discovery (ICB&DD) brings together researchers and scientists throughout Stony Brook University to study and investigate chemical biology and advance the field of drug discovery.

The Renaissance School of Medicine has selected the winners of the 2023 Faculty Awards. Every year, the RSOM recognizes faculty members who are nominated for their outstanding work in the areas of research, teaching, clinical service, mentoring and humanism—all of which are vital facets that encompass the mission of the School of Medicine.

We are delighted to announce this year's (2023) RSOM Faculty awards:

• Read more about Congratulations to Yasharah Raza on receiving awards totaling $45,000